PlainRecalls
ModerateClass IIOngoing

FDA Drug recall · Reported May 10, 2023

Advil Ibuprofen Tablets, 200 mg Pain Reliever/Fever Reducer (NSAID) packaged in a) 100-count bottles, b) 50-count bottles, and c) 3 (2 count) packets.

CGMP deviation: product outside labeled storage temperature requirements.

Recall #
D-0563-2023
Affected scope
Pending.
Initiated
March 31, 2023
Compiled from official public sources by the editorial team.
Verify with FDA Drug →
View my saved recalls

Family Dollar Stores, Llc. recalled Advil Ibuprofen Tablets, 200 mg Pain Reliever/Fever Reducer (NSAID) packaged in a) 100-co… - a moderate-severity action.

Advil Ibuprofen Tablets, 200 mg Pain Reliever/Fever Reducer (NSAID) packaged in a) 100-co… was recalled by Family Dollar Stores, Llc. in May 10, 2023. Reason: CGMP deviation: product outside labeled storage temperature requirements.. Check the official notice for the remedy. Verify recall #D-0563-2023 with the FDA Drug before acting.

The recall

Family Dollar Stores, Llc. issued this moderate-severity FDA Drug recall-CGMP deviation: product outside labeled storage temperature requirements..

Moderate
severity level
Class II
classification
May 10, 2023
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0563-2023 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0563-2023) was formally reported on May 10, 2023, with the manufacturer initiating the action on March 31, 2023. It is classified under Moderate severity (Class II), with a current status of Ongoing. Family Dollar Stores, Llc. is listed as the recalling firm, operating out of Chesapeake, VA. Federal records list the affected scope as Pending..

The documented reason for this recall is: CGMP deviation: product outside labeled storage temperature requirements. Distribution data in the federal record shows the product reached: Nationwide within the United States. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category - 14,287 drugs & medications recalls on record

-50005001,0001,5002,000 2006201220152018202120242026 263
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

Pending.

Related Recalls

6

5 from same agency

Product description

Advil Ibuprofen Tablets, 200 mg Pain Reliever/Fever Reducer (NSAID) packaged in a) 100-count bottles, b) 50-count bottles, and c) 3 (2 count) packets.

Reason for recall

CGMP deviation: product outside labeled storage temperature requirements.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Ongoing
Recall number D-0563-2023
Date reported May 10, 2023
Date initiated March 31, 2023
Recalling firm Family Dollar Stores, Llc.
Firm location Chesapeake, VA
Affected scope Pending.
Distribution Nationwide within the United States

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0563-2023) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Advil Ibuprofen Tablets, 200 mg Pain Reliever/Fever Reducer (NSAID) packaged in a) 100-count bottles, b) 50-count bottles, and c) 3 (2 count) packets.. Recalled by Family Dollar Stores, Llc.. Units affected: Pending..
Why was this product recalled?
CGMP deviation: product outside labeled storage temperature requirements.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 10, 2023. Severity: Moderate. Recall number: D-0563-2023.
Where was the recalled product distributed?
Distribution: Nationwide within the United States.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0563-2023) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →

Browse all Drugs & Medications recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported May 10, 2023. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.